Industry / Switzerland
Innovative Drugs Drive Market
March 2008 | Industry NewsBMI has revised its forecasts for the Swiss drug market after new figures were released by IMS Health. We now expect drug spending to reach US$5.56bn in 2012, representing a compound annual growth rate (CAGR) of 4.6%.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
